NCT03815253

Brief Summary

In this study, a 8-week, single blinded, randomized controlled clinical trial will be conducted to examine the efficacy and safety of body acupuncture in the treatment of central obesity in Hong Kong.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 24, 2019

Completed
8 days until next milestone

Study Start

First participant enrolled

February 1, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2021

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2021

Completed
Last Updated

March 16, 2021

Status Verified

March 1, 2021

Enrollment Period

2 years

First QC Date

January 12, 2019

Last Update Submit

March 15, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in waist circumference

    Waist circumference will be measured around the abdomen at the level of the umbilicus (belly button).

    0,1,2,3,4,5,6,7,8, 11, 15,18, 21, 24 weeks

Secondary Outcomes (6)

  • Changes in hip circumference

    0,1,2,3,4,5,6,7,8,9,11,15,18, 21, 24 weeks

  • Adverse events after treatment and follow up

    0,1,2,3,4,5,6,7,8, 15,18, 21, 24 weeks

  • Changes in waist-to-hip circumference ratio

    0,1,2,3,4,5,6,7,8, 15,18, 21, 24 weeks

  • Changes in Body Mass Index

    0,1,2,3,4,5,6,7,8, 15,18, 21, 24 weeks

  • Changes in body fat percentage

    0,1,2,3,4,5,6,7,8, 15,18, 21, 24 weeks

  • +1 more secondary outcomes

Study Arms (2)

Acupuncture group

EXPERIMENTAL

Body electro-acupuncture will be conducted for 2 sessions per week over 8 consecutive weeks. Body electro-acupuncture will choose eight acupoints as Tianshu(ST-25), Daheng(SP-15), Daimai(GB-26), Qihai(CV-6), Zhongwan(CV-12), Zusanli (ST-36), Fenlong(ST-40), Sanyinjiao(SP-6).Disposable acupuncture needles (verum acupuncture needles asia-med Special No. 16 with 0.30 x 0.30mm matching the Streitberger sham-needles) will be inserted at a depth of 10-25 mm into the points. We will also deliver electrical stimulation with dense-disperse waves with 50Hz at 10 volts through electrical acupuncture stimulation instrument (ES-160 6-Channel Programmable Electro-acupuncture) to the abdominal points. The bodily needles will be retained for 30 minutes.

Other: acupuncture

sham-acupuncture group

PLACEBO COMPARATOR

As to the participants allocated to control group, Streitberger's non-invasive acupuncture needles (Gauge 8 x 1.2" / 0.30 x 30 mm) will be applied to act as sham control at the same acupoints with same stimulation modality. However, the needles will be only adhered to the skin instead of insertion. The validity and credibility of this model has been well demonstrated.

Other: acupuncture

Interventions

Body electro-acupuncture will choose eight acupoints as Tianshu(ST-25), Daheng(SP-15), Daimai(GB-26), Qihai(CV-6), Zhongwan(CV-12), Zusanli (ST-36), Fenlong(ST-40), Sanyinjiao(SP-6).Disposable acupuncture needles (verum acupuncture needles asia-med Special No. 16 with 0.30 x 0.30mm matching the Streitberger sham-needles) will be inserted at a depth of 10-25 mm into the points. We will also deliver electrical stimulation with dense-disperse waves with 50Hz at 10 volts through electrical acupuncture stimulation instrument (ES-160 6-Channel Programmable Electro-acupuncture) to the abdominal points. The bodily needles will be retained for 30 minutes.

Acupuncture groupsham-acupuncture group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who meet all of the following criteria are defined as eligible participants: men and women aged between 18 and 65 years old; BMI ≥ 25 kg/m2; central obesity, defined as WC of ≥ 90 cm in men and ≥ 80 cm in non-pregnant women according to ICD-10 \[24\]; not receiving any other weight control measures or any medical and/or drug history in last 3months.

You may not qualify if:

  • Patients who meet any of the following criteria should be excluded from the study: endocrine diseases, including thyroid disorder, pituitary disorder, sex gland disorder, etc.; heart diseases, including arrhythmia, heart failure, myocardial infarction, patients with pacemaker; allergy and immunology diseases; bleeding tendency; pregnant or lactating women; impaired hepatic or renal function; stroke or unable to exercise.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Linda Zhong

Kowloon Tong, Kowloon, Hong Kong

Location

Related Publications (2)

  • Lam TF, Lyu Z, Wu X, Wong YP, Cao P, Wong EY, Hung HB, Zhang S, Bian Z, Zhong LLD. Electro-acupuncture for central obesity: a patient-assessor blinded, randomized sham-controlled clinical trial. BMC Complement Med Ther. 2024 Jan 29;24(1):62. doi: 10.1186/s12906-024-04340-5.

  • Zhong LLD, Wu X, Lam TF, Wong YP, Cao P, Wong EY, Zhang S, Bian Z. Electro-acupuncture for central obesity: randomized, patient-assessor blinded, sham-controlled clinical trial protocol. BMC Complement Med Ther. 2021 Jul 3;21(1):190. doi: 10.1186/s12906-021-03367-2.

MeSH Terms

Conditions

Obesity, Abdominal

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Zhaoxiang Bian, MD., Ph.D

    Hong Kong Chinese Medicine Clinical Study Centre

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Subjects of both groups will be randomly assigned to receive either electro-acupuncture or control (sham) treatment. For randomization, simple, complete non-sequential random numbers will be generated in advance by a computer program in a block of four, and kept by the principal investigator. After a patient's eligibility is confirmed, a randomization number which corresponds to the group allocation will be provided to the acupuncturist by the PI. This arrangement will ensure that the clinical assessor and participants are blinded to the allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: single-blinded, randomized, sham-controlled clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant Professor

Study Record Dates

First Submitted

January 12, 2019

First Posted

January 24, 2019

Study Start

February 1, 2019

Primary Completion

January 31, 2021

Study Completion

February 28, 2021

Last Updated

March 16, 2021

Record last verified: 2021-03

Locations